Three projects awarded under the 2022 "Subsidy scheme for promising care" in the Netherlands

In September 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which were awarded a total amount of €5.3 million under round 5 of the subsidy scheme for Promising care in 2022:

• Research into PET/CT scan instead of CT scan for post-screening in lung cancer;
• Promising treatment for head and neck cancer that spares lymph nodes in the neck;
• New research on surgery to prevent lymphedema after cancer treatment

The research into PET/CT scan instead of CT scan for people who have already been treated for stage III lung cancer and are starting additional immunotherapy or aftercare was awarded a subsidy of €2.5 million within the framework of the "Subsidy scheme for promising care". The project will start in April 2023. It will be supervised by the Radboud UMC in Nijmegen and last for six years. After completing the project, the research results will be submitted to the ZIN around April 2029 for the decision about inclusion in the Basic Health Insurance. The publication of the ZIN position on reimbursement under the Basic Insurance Package is scheduled for October 2029.

The aim of the study of promising treatment for head and neck cancer that spares lymph nodes is to determine whether this new method of treatment produces as good or better results as the standard treatment. The study was awarded a subsidy of €1.2 million within the framework of the "Subsidy scheme for promising care". The project led by Radboud UMC in Nijmegen will start in April 2023 and last for six years. After completing the project, the research results will be submitted to the ZIN around April 2029 for the decision about inclusion in the Basic Health Insurance. The publication of the ZIN position on reimbursement under the Basic Insurance Package is scheduled for mid-October 2029.

The research on surgery to prevent lymphedema after cancer treatment was awarded a subsidy of €1.6 million within the framework of the "Subsidy scheme for promising care". The project will start in March 2023. It will be supervised by the Maastricht UMC and last for six years. After completing the project, the research results will be submitted to the ZIN around March 2029 for the decision about inclusion in the Basic Health Insurance. The publication of the ZIN position on reimbursement under the Basic Insurance Package is scheduled for August 2029.

The full details in Dutch can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).